Among the so-called extra-criteria aPL tests, besides aPS/PT, antiβ2GPI-domain1 antibodies have been also proposed to potentially improve the diagnostic accuracy in patients with suspected APS (28, 29), especially when assessing the risk for both thrombosis and pregnancy morbidity. Here, F2 is linked to autoimmune polyendocrinopathy.